Skip to main content
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1978 Aug;6(2):145–148. doi: 10.1111/j.1365-2125.1978.tb00839.x

Irradiation of human skin by short wavelength ultraviolet radiation (100--290 nm) (u.v.C): increased concentrations of arachidonic acid and prostaglandines E2 and F2alpha.

R D Camp, M W Greaves, C N Hensby, N A Plummer, A P Warin
PMCID: PMC1429404  PMID: 678391

Abstract

1. Human abdominal skin was irradiated with six times the minimal erythema dose of ultraviolet C (100--290 nm) radiation. Erythema appeared at 3 h, was of moderate degree by 6 h and was maximal at 12--24 h. It was reduced at 48 h and by 72 h had disappeared. 2. A suction bulla technique was used for the recovery of exudate from normal and inflamed skin at 6, 18, 24 and 48 h after irradiation. 3. Prostaglandin-like activity, estimated by bioassay, showed maximum increase at 18 h, when erythema was also maximum. PGF 2alpha, measured by both radioimmunoassay and by combined gas-liquid chromatography--gas spectrometry, followed a similar time course then fell to normal, or near normal, levels at 48 h. 4. Prostaglandin E2 and arachidonic acid concentrations, measured by gas chromatography--mass spectrometry, were maximally raised at 18--24 h. At 48 h, when some erythema was still present, though reduced, prostaglandin E2 concentrations were still raised above control values. 5. The results provide direct evidence in support of the view that the erythma following irradiation of human skin by u.v.C involves activation of arachidonic acid metabolism. However, the relationship between the erythema and increased prostaglandin activity is not fully understood.

Full text

PDF
145

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. BACHEM A. Time factors of erythema and pigmentation, produced by ultraviolet rays of different wavelengths. J Invest Dermatol. 1955 Oct;25(4):215–218. doi: 10.1038/jid.1955.123. [DOI] [PubMed] [Google Scholar]
  2. Black A. K., Greaves M. W., Hensby C. N., Plummer N. A., Eady R. A. A new method for recovery of exudates from normal and inflamed human skin. Clin Exp Dermatol. 1977 Sep;2(3):209–216. doi: 10.1111/j.1365-2230.1977.tb02560.x. [DOI] [PubMed] [Google Scholar]
  3. Black A. K., Greaves M. W., Hensby C. N., Plummer N. A. Increased prostaglandins E2 and F2alpha in human skin at 6 and 24 h after ultraviolet B irradiation (290- 320 nm). Br J Clin Pharmacol. 1978 May;5(5):431–436. doi: 10.1111/j.1365-2125.1978.tb01650.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Dighe K. K., Emslie H. A., Henderson L. K., Simon L. The development of antisera to prostaglandins B2 and F2alpha and their analysis using solid-phase and double antibody radioimmunoassay methods. Br J Pharmacol. 1975 Dec;55(4):503–514. doi: 10.1111/j.1476-5381.1975.tb07425.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Eaglstein W. H., Marsico A. R. Dichotomy in response to indomethacin in UV-C and UV-B induced ultraviolet light inflammation. J Invest Dermatol. 1975 Aug;65(2):238–240. doi: 10.1111/1523-1747.ep12598255. [DOI] [PubMed] [Google Scholar]
  6. Everett M. A., Yeargers E., Sayre R. M., Olson R. L. Penetration of epidermis by ultraviolet rays. Photochem Photobiol. 1966 Jul;5(7):533–542. doi: 10.1111/j.1751-1097.1966.tb09843.x. [DOI] [PubMed] [Google Scholar]
  7. Gilmore N., Vane J. R., Wyllie J. H. Prostaglandins released by the spleen. Nature. 1968 Jun 22;218(5147):1135–1140. doi: 10.1038/2181135a0. [DOI] [PubMed] [Google Scholar]
  8. VANE J. R. THE USE OF ISOLATED ORGANS FOR DETECTING ACTIVE SUBSTANCES IN THE CIRCULATING BLOOD. Br J Pharmacol Chemother. 1964 Oct;23:360–373. doi: 10.1111/j.1476-5381.1964.tb01592.x. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES